An Open-Label, MultiCenter Study of Evaluated the Effects of ASA404 alone and in combination with Taxane-Based Chemotherapy on the Pharmacokinetics of Simvastatin, Caffeine, Omeprazole, and Diclofenac in Patients with Advanced Solid Tumor Malignancies
|Effective start/end date||7/2/09 → 4/27/10|
- Novartis Pharma AG
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.